KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Imax (IMAX) Research & Development (2016 - 2025)

Imax (IMAX) has disclosed Research & Development for 16 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 26.17% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.8 million through Dec 2025, up 13.97% year-over-year, with the annual reading at $5.8 million for FY2025, 13.97% up from the prior year.
  • Research & Development hit $1.5 million in Q4 2025 for Imax, down from $1.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $2.8 million in Q3 2023 to a low of -$265000.0 in Q3 2024.
  • Historically, Research & Development has averaged $1.7 million across 5 years, with a median of $1.5 million in 2025.
  • Biggest five-year swings in Research & Development: crashed 109.56% in 2024 and later skyrocketed 667.92% in 2025.
  • Year by year, Research & Development stood at $1.2 million in 2021, then soared by 30.85% to $1.6 million in 2022, then skyrocketed by 66.69% to $2.7 million in 2023, then crashed by 57.75% to $1.2 million in 2024, then rose by 26.17% to $1.5 million in 2025.
  • Business Quant data shows Research & Development for IMAX at $1.5 million in Q4 2025, $1.5 million in Q3 2025, and $1.5 million in Q2 2025.